2022, Número S5
<< Anterior Siguiente >>
Cardiovasc Metab Sci 2022; 33 (S5)
Cáncer y su impacto en el riesgo cardiovascular
Peix-González A, Agüero RN, Feijóo-Iglesias J, Lapresa S, Lara-Veitia H, Nuriulú-Escobar PL
Idioma: Inglés [English version]
Referencias bibliográficas: 10
Paginas: s484-486
Archivo PDF: 124.66 Kb.
REFERENCIAS (EN ESTE ARTÍCULO)
Koene RJ, Prizment AE, Blaes A, Konety SH. We shared risk factors in cardiovascular disease and cancer. Circulation. 2016; 133: 1104-1114.
Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation. 2018; 137: e30-e66.
Armstrong GT, Oeffinger KC, Chen Y, Kawashima T, Yasui Y, Leisenring W et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013; 31: 3673-3680.
Navarrete S, Castellanos AM, Chaparro A. Cardiotoxicidad por quimioterapia: Un enfoque práctico para el clínico. Insuf Card. 2011; 6: 131-143.
Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016; 37 (36): 2768-2801.
López-Fernández T, Martín García A, Santaballa Beltrán A, Montero Luis A, García Sanz R, Mazón Ramos P et al. Cardio-onco-hematology in clinical practice. position paper and recommendations. Rev Esp Cardiol (Engl Ed). 2017; 70 (6): 474-486.
Michel L, Mincu RI, Mahabadi AA, Settelmeier S, Al Rashid F, Rassaf T et al. Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis. Eur J Heart Fail. 2020; 22: 350-361.
Dent SF. Practical cardio-oncology. New York: CRC Press; 2020. p. 260.
Thavendiranathan P, Negishi K. Detection of subclinical heart failure. In: Marwick T, Abraham T. ASE's comprehensive strain imaging. Elsevier; 2021. pp. 20-50.
Mitchell JD, Cehic DA, Morgia M, Bergom C, Toohey J, Guerrero PA et al. Cardiovascular manifestations from therapeutic radiation: a multidisciplinary expert consensus statement from the International Cardio-Oncology Society. JACC CardioOncol. 2021; 3 (3): 360-380.